Phio Pharmaceuticals Corp. (PHIO) (CIK 0001533040) CORRESP

Phio Pharmaceuticals Corp. (PHIO) (CIK 0001533040) → SEC staff · filed 2025-12-01 · ticker PHIO · SIC 2834 · view PDF on sec.gov ↗
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.

Key facts

Accession number
0001683168-25-008768
Form
CORRESP
Filer
Phio Pharmaceuticals Corp. (PHIO) (CIK 0001533040)
CIK
0001533040
Ticker
PHIO
Filed
2025-12-01
SIC industry
2834
HQ
King of Prussia, PA

Primary source

PDF letter: https://www.sec.gov/Archives/edgar/data/1533040/000168316825008768/filename1.htm

EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗